Longevity Metrics AI/ML Development Study

计划入组 1,000,000 人 · 首次发布于 2026 年 9 月 9 日

Clinical Evaluation of the V5-LU01 AI Software in Thoracic CT for V5med Inc.

计划入组 16 人 · 首次发布于 2024 年 7 月 23 日

Behavioral Interventions Combining AI/ML and Personalized Medicine to Reduce Cardiovascular Risk - Randomized Controlled Trial

计划入组 3,000 人 · 首次发布于 2026 年 7 月 24 日

AI-071

AI-061

AI-520

ML Bio Solutions Inc

United States

ML Bio Solutions, Inc.

United States

Renalytix AI, Inc.

United States

AIML Secures $2.17 Million in Oversubscribed Private Placement for AI Healthcare Innovations

AIML Innovations Secures Provisional Patents for AI-Powered ECG Signal Processing Technology

FDA Grapples with AI/ML Medical Device Oversight: Regulatory Gaps and Bias Concerns Emerge